In our immunohistochemical analysis, we found that the expression of tetranectin in the epithelial cells of bone metastasis tissues, prostate cancer tissues with bone metastasis, prostate cancer tissues without metastasis and prostatic hyperplasia tissues decreased in that order. Here, CLEC3B is linked to prostate disorder.